Enabling early to late phase clinical trials for drug development programs
Syngene’s clinical development services team enables early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.
Our services include clinical trial management, pharmacokinetic (PK) analysis and bioanalytical studies of small molecules and biologics, biometrics and clinical data management, and Syngene’s central lab services. We also provide regulatory services for all stages of drug development, medical monitoring services, pharmacovigilance solutions, and medical writing for clinical study documents.
Syngene strives to attract and retain the best talent in the industry while providing world-class infrastructure and systems to support various research and development activities. Over the last 15 years, we have built an impeccable track record for data confidentiality through a well-established system. We have also implemented a comprehensive business continuity and disaster recovery plan.